
Christopher S. Stach
Featured in:
biorxiv.org
Articles
-
Feb 15, 2024 |
biorxiv.org | Adam Sychla |Christopher S. Stach |Amanda Hayward |Shanley Roach
AbstractReplication-incompetent single cycle infectious Influenza A Virus (sciIAV) has demonstrated utility as a research and vaccination platform. Protein-based therapeutics are increasingly attractive due to their high selectivity and potent efficacy but still suffer from low bioavailability and high manufacturing cost.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →